Efficacy and Safety of Paclitaxel, Ifosfamide and Cisplatin as First-line Treatment on Patients with Intermediate- or Poor-risk Advanced Testicular Cancer
Objective To assess the efficacy and safety of paclitaxel, ifosfamide and cisplatin (TIP) as the first-line treatment for the patients with intermediate- or poor-risk testicular cancer retrospectively. Methods Patients with intermediate- or poor-risk testicular cancer in our center received TIP as t...
Main Authors: | ZHOU Li, CHI Zhihong, CUI Chuanliang, SHENG Xi'nan, SI Lu, TANG Bixia, MAO Lili, WANG Xuan, YAN Xieqiao, LIAN Bin, LI Siming, BAI Xue, GUO Jun |
---|---|
Format: | Article |
Language: | zho |
Published: |
Magazine House of Cancer Research on Prevention and Treatment
2018-06-01
|
Series: | Zhongliu Fangzhi Yanjiu |
Subjects: | |
Online Access: | http://html.rhhz.net/ZLFZYJ/html/8578.2018.17.1417.htm |
Similar Items
-
Effect of monosodium glutamate on testicular tissue of paclitaxel-treated mice: An experimental study
by: Davoud Kianifard, et al.
Published: (2019-11-01) -
Paclitaxel, Ifosfamide, and Cisplatin in Patients with Poor-prognosis Disseminated Nonseminomatous Germ Cell Tumors with Unfavorable Serum Tumor Marker Decline After First Cycle of Chemotherapy. The GCT-SK-003 Phase II Trial
by: Michal Mego, et al.
Published: (2021-11-01) -
Testicular microlithiasis and testicular tumor: a review of the literature
by: Louis Leblanc, et al.
Published: (2018-07-01) -
Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer
by: Alan C. Cameron, MBChB, PhD, et al.
Published: (2020-09-01) -
Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives
by: João Lobo, et al.
Published: (2020-06-01)